Peernova Raises $31 Million in New Funding for Global Expansion

Peernova, an enterprise blockchain software startup that helps banks and financial institutions simplify reconciliation and other data processes, has raised $31 million in new funding.

Intuitive Venture PartnersOctober 24, 20192019, peernova

Angion Announces Strategic Additions to Management Team

Angion Biomedica Corp. (NASDAQ: ANGN) announces several strategic additions to its management team to support the future development and commercialization of ANG-3777

Intuitive Venture PartnersOctober 15, 20192019, angion

Angion Presents Late-Breaking Data on ANG-3777

Angion Biomedica Corp. (NASDAQ: ANGN) presents late-breaking data on ANG-377 in delayed graft function at the American Society of Nephrology Kidney Week 2019.

Intuitive Venture PartnersOctober 11, 20192019, angion

Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company

Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) to merge with RDD Pharma creating new gastroenterology company focused on specialty, rare and orphan diseases.

Intuitive Venture PartnersOctober 7, 2019innovate biopharmaceuticals, 2019

Entera Bio Reports Positive Results From a Phase 2 PK/PD Study

Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) reports positive results from a phase 2 PK/PD study of Oral PTH (1-34) in patients with hypoparathyroidism.

Intuitive Venture PartnersSeptember 23, 2019entera bio, 2019

HZO Inc. Raises $70 Million in New Financing

HZO Inc. announced today that it has closed on $70 million in a new financing round.

Intuitive Venture PartnersApril 23, 2019HzO, 2019

Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) announced that three abstracts were accepted for presentations during the 2019 Digestive Disease Week (DDW) conference.

Intuitive Venture PartnersFebruary 25, 2019innovate biopharmaceuticals, 2019

Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with the National Cancer Institute

Neurotrope, Inc. (NASDAQ: NTRP) announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1.

Intuitive Venture PartnersFebruary 4, 2019neurotrope, 2019

Entera Bio Announces Positive Feedback and Guidance from the US FDA

Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today the positive outcome of a pre-IND meeting held with the US Food and Drug Administration (FDA) to disscuss the Company’s development plan for Oral PTH for the treatment of osteoporosis.

Intuitive Venture PartnersJanuary 31, 2019entera bio, 2019

Angion Completes Equity Financing and Appoints Senior Executives

Angion Biomedica Corp. (NASDAQ: ANGN), a late-stage clinical biopharmaceutical company focused on kidney diseases and other acute organ injuries, announces the recent closing of a $35 million equity private placement.

Intuitive Venture PartnersJanuary 4, 2019angion, 2019